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988Objective: Up to 20% of fetuses with critical left heart obstructive lesions have highly restrictive or intact atrial
septae. Although this condition is generally tolerated in utero, severe hypoxemia requiring emergency atrial sep-
tostomy often develops in newborns with restrictive atrial septum. We have reported that a pulmonary venous
Doppler forward/reverse time-velocity integral ratio less than 5 is highly predictive of the need for emergency
atrial septostomy. We reviewed our subsequent experience using fetal pulmonary venous Doppler patterns to
identify and manage fetuses with critical left heart obstruction and suspected restrictive atrial septum.
Methods: A retrospective review of neonates with a prenatal diagnosis of critical left heart obstruction was per-
formed. Fetal restrictive atrial septum was defined as a small/absent interatrial shunt on 2-dimensional imaging
and a mean forward/reverse time-velocity integral ratio of 5 or less. Available serial pulmonary venous Doppler
data were reviewed. The primary outcome was postnatal confirmation of restrictive atrial septum or severe left
atrial hypertension.
Results: Eight of 39 infants had a forward/reverse time-velocity integral ratio of 5 or less. A restrictive atrial
septum was confirmed postnatally in 6 of 8 infants. Overall, a forward/reverse time-velocity integral ratio of
5 or less had a sensitivity of 100% and specificity of 94% for emergency atrial septostomy. Lowering the cutoff
value to 3 or less would have eliminated false-positive diagnoses in the current series. Serial data demonstrated
that late second trimester values did not change in later gestation with respect to either threshold in 30 of 32
fetuses.
Conclusions: In the fetus with critical left heart obstruction, a threshold forward/reverse time-velocity integral
ratio of 3 or less optimizes specificity for predicting emergency atrial septostomy. Most late second trimester
values will not change over time with regard to threshold levels. (J Thorac Cardiovasc Surg 2011;141:988-94)The incidence of hypoplastic left heart syndrome is estimated
at 0.16 to 0.36 per 1000 live births, with 6% to 20% of those
infants found to have a restrictive or intact atrial septum
(RAS).1-4 Although this is generally well tolerated in utero,
these infants often experience severe postnatal hypoxemia
and left atrial hypertension, which can quickly lead to
cardiovascular collapse if an emergency atrial septostomy
(EAS) is not performed. Prenatal identification of such
infants is important because it often affects counseling and
the delivery strategy of these mothers. In the current era of
fetal therapy, some centers have performed cesarean
sections (C/S) in a pediatric operating room or hybrid
catheterization laboratory to further shorten the intervale Fetal Heart Program, Division of Cardiology, Cincinnati Children’s Hospi-
edical Center, Cincinnati, Ohio.
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The Journal of Thoracic and Cardiovascular Surgbetween birth and EAS.5,6 Select centers have even
performed in utero therapies to decompress the left atrium
and allow for left to right shunting.1-3,7-9 In this setting,
accurate prenatal diagnosis of RAS in infants with critical
left heart obstruction (CLHO) is critical in patient selection
for fetal cardiac interventions or a maternal C/S to ensure
timely intervention on the atrial septum.
Prenatal diagnosis of a restrictive atrial septum takes into
account multiple factors, including the 2-dimensional ap-
pearance of the septum, gradient across the interatrial shunt,
and pulmonary venousDoppler (PVD) flow patterns. Pulsed
PVDflowpatterns have been assessed both in normal fetuses
and in fetuses with CLHO.10-16 We reported in 2005 that
a PVD forward/reverse velocity time integral (FR VTI)
ratio less than 5 was highly predictive—maximizing both
sensitivity and specificity—of the need for EAS in the
fetus with CLHO.12
The purpose of this study was to (1) review our subse-
quent experience using fetal PVD patterns (specifically,
an FRVTI threshold value<5) in identification and perina-
tal management of fetuses with CLHO and RAS; and (2)
evaluate longitudinal variation of PVD flow indices be-
tween late second and third trimester fetal assessments.ery c April 2011
FIGURE 1. Measurement of forward-flow VTI (combined S and D
waves) and reverse-flow VTI (A wave). VTI, Time-velocity integral.
Abbreviations and Acronyms
CLHO ¼ critical left heart obstruction
C/S ¼ cesarean section
EAS ¼ emergency atrial septostomy
ECMO ¼ extracorporeal membrane oxygenation
EXIT ¼ ex utero intrapartum therapy
FR VTI ¼ forward/reverse velocity time integral
PVD ¼ pulmonary venous Doppler
RAS ¼ restrictive or intact atrial septum
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Study Population
Weconducted a retrospective reviewof fetuseswithCLHOlesions at risk
for possible pulmonary venous obstruction and left atrial hypertension sec-
ondary to RAS. All data collection and storagewere done under approval of
the institutional review board to ensure proper handling of protected health
information under the Health Information Portability and Accountability
Act. The study population included infants with the prenatal diagnosis of
CLHO, primarily consisting of hypoplastic left heart syndrome or double-
outlet right ventricle with mitral atresia, studied by fetal echocardiogram
between June 2004 and August 2009 who were treated at the Cincinnati
Children’s Hospital Medical Center. Fetuses with unbalanced atrioventric-
ular canal defects were not included in the analysis. Serial data were col-
lected in fetuses, 2 of which had late third trimester ratios included in our
previous report, with at least 2 studies performed 4 or more weeks apart,
with the initial study performed at 28 weeks or less gestation. Comparison
between the initial study and the last study was performed to evaluate serial
change in FR VTI ratio. Only the last study before delivery was used to
assess the clinical performance of using a PVD FRVTI ratio of 5 or less.
Fetal Echocardiography
Fetal echocardiograms were performed on Sequoia C512 (Siemens
Corp, Mountain View, Calif) machines under direct supervision of a cardi-
ologist experienced in fetal echocardiography. Complete 2-dimensional,
color flow, and spectral Doppler studies were performed by use of accepted
standards to establish the anatomic diagnosis.17 Particular attention was de-
voted to evaluation of the patency of the foramen ovale by 2-dimensional
and color flow Doppler.
Pulmonary Venous Flow Analysis
Pulsed-wave Doppler evaluation of pulmonary vein flow was performed
in the right or left vein, because differences between the right and left pul-
monary vein flow have been shown to be insignificant in the fetus.18 Pulmo-
nary veins were imaged by color flow Doppler in the transverse plane.
Doppler recordings were obtained with the angle of insonation as parallel
to the direction of flow as possiblewith the sample volume placed in the pul-
monary vein immediately proximal to its entry into the left atrium, as previ-
ously described.10,14,15 Low-pass filterswere adjusted to ensure recording of
lower-velocity signals. Because our previous publication12 reported inter-
and intraobserver variability of 7% to 16% for multiple PVD measure-
ments, including FRVTI ratios, we did not readdress that in this study.
All studies were digitally acquired and stored. Doppler measurements
were made offline on commercially available digital imaging work sta-
tions. The velocity-time integral of forward flow (SþD waves) and reverse
flow (Awave) were obtained from the pulmonary venous spectral Doppler
tracings, and a forward-to-reverse VTI ratio was calculated (Figure 1). All
measurements were performed in triplicate and averaged to take into
account beat-to-beat variation.The Journal of Thoracic and CaDiagnosis of Restrictive Atrial Septum
An intact or highly restrictive atrial septum was suspected if the atrial
septum was not freely mobile or appeared thick with limited or no demon-
strable shunting on color Doppler interrogation. On the basis of our prior
work, RAS was diagnosed when a small or absent interatrial communica-
tion was present and the PVD FR VTI ratio was 5 or less.12 Presence
of decompressing venous channels, patent mitral valve inflow, and left
ventricular size were not used as criteria in determining the likelihood of
RAS.
Clinical Management
Cincinnati Children’s Hospital Medical Center is a large, freestanding
tertiary care pediatric center. Ambulance transfer of acutely ill neonates
from all birthing centers in our referral area is therefore necessary. With
these logistics inmind, 3 treatment planswerediscussed in detail andoffered
to familieswhen fetal RASwas identified: (1) standard delivery at an outside
hospital and immediate transfer to the catheterization laboratory (cardiac in-
tensive care unit); (2) C/S in a hybrid catheterization laboratory/operating
room for EAS; or (3) ex utero intrapartum therapy-to-extracorporeal
membrane oxygenation (EXIT-to-ECMO) with EAS on ECMO. During
an EXIT procedure, the head of the infant is delivered via C/S so that
ECMO support can be initiated before separation of the infant from the pla-
centa. In all cases, the final delivery strategy decided on was individualized
on the basis of consensus among the patient, maternal-fetal-medicine
specialist, and cardiologist.
Postnatal Data
For the purpose of analysis, confirmation of RAS in the newborn period
was used as the primary clinical outcome variable. RAS was confirmed
postnatally by (1) clinical status, based on the degree of hypoxemia,
acidosis, postnatal echo findings, or suspicion of significant left atrial
hypertension; or (2) direct left atrial pressure measurement at cardiac cath-
eterization (in 2 subjects undergoing EXIT-to-ECMO).
Statistical Analysis
Descriptive data are reported as mean  standard deviation. Non-
normal data are presented as median and range. Sensitivity, specificity,rdiovascular Surgery c Volume 141, Number 4 989
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using the predetermined cut point of 5 or less, which was based on our
prior receiver operating curve analysis.12 Values for these same indices
were also determined if the cut point was hypothetically lowered to 3 or
less. Statistical analysis was performed using StatView v5.0 (SAS Institute
Inc, Cary, NC).RESULTS
Study Population
As in our original study,12 perinatal management was
guided by PVD in 41 consecutive patients with a prenatal
diagnosis of CLHO. Two infants were excluded from anal-
ysis. One infant was excluded because of the presence of
hypoplastic left heart syndrome in the setting of a geneti-
cally confirmed familial cardiomyopathy with restrictive
physiology. A second infant with aortic stenosis and severe
mitral insufficiency was excluded because of an unusual
PVD profile with a dominant D wave, no visible S wave,
and a moderate A-wave reversal that precluded normal
analysis of FR VTI ratio. The mean gestational age at lastFIGURE 2. Flowchart outlining the clinical accuracy of using a PVD FRVTI ra
time-velocity integral; RAS, restrictive atrial septum; C/S, cesarean section;
oxygenation.
990 The Journal of Thoracic and Cardiovascular Surgstudy before delivery was 33  2 weeks. All fetuses were
in a normal cardiac rhythm with 1:1 atrioventricular con-
duction at the time of PVD study. A total of 32 fetuses
had a serial PVD assessment with a mean of 3  1 studies.
Two of these fetuses had late third trimester data included in
our prior report. The serial PVD data from these 2 fetuses
were included only in the analysis of longitudinal data,
but not in the analysis of clinical test performance. The
mean gestational age at initial fetal echocardiogram in
this cohort was 24  2 weeks.Clinical Performance of Pulmonary Venous Doppler
Forward/Reverse Velocity Time Integral Ratio in
Predicting Restrictive or Intact Atrial Septum
PVD findings, clinical accuracy, and clinical outcomes
for the entire study cohort are summarized in Figure 2.
PVD tracings were uniformly possible in all study subjects
and generally of good quality even in the setting of marginal
acoustic windows.tio less than 5. PVD, Pulmonary venous Doppler;FR, forward/reverse; VTI,
EXIT, ex utero intrapartum treatment; ECMO, extracorporeal membrane
ery c April 2011
TABLE 1. Clinical data and immediate outcome in eight fetuses with pulmonary venous Doppler forward/reverse time-velocity integral ratios less
than 5
Last prenatal
FR VTI Delivery mode Diagnosis
IAS on
postnatal study? Intervention Initial palliation Mortality<30 d
TP 1.6 EXIT-to-ECMO Critical AS Yes BAV Aortic homograft Yes
2.2 EXIT-to-ECMO HLHS No BAS Norwood* No
0.9 C/S in hybrid laboratory HLHS Yes BAS/stent Norwood* No
1 Preterm, standard HLHS Yes Failed BAS N/A Yes
2.8 C/S in hybrid laboratory HLHS No Surgical septectomy Norwood* No
2.9 C/S in hybrid laboratory HLHS No BAS N/A Yes
FP 3.6 Standard HLHS No None Norwood w/Sano*,y Yes
3.5 C/S in fetal OR HLHS No None Norwood* Yes
TP, True positive; FP, false positive; FR VTI, forward/reverse velocity time integral; IAS, intact atrial septum; C/S, cesarean section; OR, operating room; EXIT, ex utero intra-
partum therapy; ECMO, extracorporeal membrane oxygenation; BAV, balloon aortic valvuloplasty; BAS, balloon atrial septostomy. *Norwood procedure: palliative procedure
used for infants with hypoplastic left heart syndrome in whom the pulmonary artery and diminutive ascending aortic are connected, homograft is used to reconstruct the aortic
arch, and pulmonary blood flow is supplied by an artificial tube graft (traditionally a Blalock–Taussig shunt from the innominate artery to the right pulmonary artery). ySano: shunt
from the right ventricle to the right pulmonary artery (alternative to the Blalock–Taussig shunt).
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fied as having RAS by the appearance of the atrial septum
on 2-dimensional/color flow Doppler imaging and a PVD
FRVTI ratio of 5 or less. The clinical data in these 8 fetuses
are summarized in Table 1. Six fetuses required EAS/bal-
loon valvuloplasty in the immediate newborn period. Of
those 6 infants, 2 underwent EXIT-to-ECMO, 3 were deliv-
ered in the hybrid laboratory for immediate EAS, and 1 was
delivered preterm in a precipitous fashion at an outside de-
livery hospital. The infants who underwent EXIT-to-ECMO
were documented to have left atrial hypertension with mean
left atrial pressures of 18 and 40 mm Hg, respectively. One
infant underwent EXIT-to-ECMO and aortic balloon valvu-
loplasty while on ECMO support, because she was thought
to have only mild left ventricular hypoplasia on postnatal
echocardiography, and the clinical decision was to pursue
an attempt at biventricular physiology. One infant under-
went surgical septectomy in the hybrid catheterization suite
immediately after unsuccessful transcatheter balloon sep-
tostomy. Ultimately, the decision to perform EASwas based
on the consensus among the intensive care, echocardiogra-
phy, and cardiac interventionalist personnel who were pres-
ent at the time of delivery. In general, findings included
severe hypoxemia, acidosis, and echocardiography con-
firming RAS at the time of intervention.
There were 2 false-positive results (Table 1). One infant
was delivered via C/S in the hybrid laboratory, and 1 infant
was delivered in standard fashion. Postnatal echocardiogra-
phy in each baby confirmed restriction of left-to-right shunt-
ing across the atrial septum with mean gradients of 10 to 12
mm Hg. Despite this, both infants had persistent oxygen sat-
urations greater than 80% after initial neonatal resuscitation
without evidence ofpulmonary congestiononchest x-ray, dif-
ficulty with ventilation, or increased lactate levels. The Nor-
wood procedure was performed on day 2 of life in each case.
The overall prevalence of RAS in infants with CLHOwas
15% (6/39). In clinical application, a PVD FRVTI ratio of 5The Journal of Thoracic and Caor less had an overall sensitivity of 100%, specificity of
94%, negative predictive value of 100%, and positive pre-
dictive value of 75%. Lowering the cutoff value to 3 or less
would have resulted in elimination of all false-positive find-
ings in this series without an observed change in sensitivity.
Serial Evaluation of Pulmonary Venous Doppler
Forward/Reverse Velocity Time Integral Ratio
Thirty-two fetuses were included in the longitudinal eval-
uation. The mean gestational age at the time of initial study
was 24  2 weeks. The follow-up period ranged from 4 to
17 weeks with a median of 9 weeks. Serial changes in PVD
FRVTI ratio relative to cut points of 5 or less and 3 or less
are presented in Figure 3. In 7 of 8 fetuses (88%) with
a PVD FRVTI ratio of 5 or less on their initial echocardio-
gram, the ratio remained 5 or less during late gestation and
correlated with RAS postnatally in 6 of 8. One fetus had a ra-
tio of less than 5 over 2 studies and did not require EAS.
One fetus had repeat ratios more than 5 and did not require
EAS. There were 24 fetuses with ratios more than 5 on their
initial echocardiogram, all of which remained more than 5
during late gestation and correlated with an unrestrictive
atrial septum.
In subjects with an initial PVD FRVTI ratio of 3 or less, 5
of 6 fetuses had ratios of 3 or less on both the initial and final
study (although some had intermediate values> 3); all 5
went on to require postnatal EAS. One of 6 fetuses who
had an initial ratio of 3 and a follow-up ratio between 3
and 5 did not require postnatal EAS. Overall, 30 of 32
(94%) of late second trimester PVD FR VTI ratios were
predictive of values obtained during the third trimester.
Postnatal Findings and Outcome
Decompressing venous channels were present postna-
tally in 3 of 6 subjects requiring EAS and 3 of 33 subjects
with unrestrictive atrial septal defects. Three of 6 neonates
who required emergency newborn intervention had anrdiovascular Surgery c Volume 141, Number 4 991
FIGURE 3. Longitudinal changes in serial FR VTI data using the initial
ratio and the last ratio obtained before delivery. Numbers indicate number
of subjects in each range. Note only 2 subjects had FR VTI ratios that
crossed (diagonal lines) over the thresholds of 5 or less and 3 or less.
FR, Forward/reverse; VTI, time-velocity integral.
FIGURE 4. Pulmonary venous Doppler profiles in 3 fetuses with CLHO
who required EAS in the newborn period. Note the variability in the FRVTI
ratios. FR, Forward/reverse; VTI, time-velocity integral.
Congenital Heart Disease Divanovic et al
C
H
Dintact atrial septum on postnatal echocardiogram, and the
remaining 3 neonates had restrictive atrial level defects.
Short-term follow-up was available for all infants. Thirty-
day survival for infants undergoing EAS was 50% (3/6).
One infant, delivered precipitously preterm and urgently
transported, died of severe hypoxemia and acidosis during
attempted EAS. One infant died after EAS but before surgi-
cal intervention.
DISCUSSION
Our data demonstrate that PVD flow patterns, assessed in
the late second or third trimester by fetal echocardiography,
can reliably identify fetuses with CLHO who will require
EAS in the newborn period. These findings establish assess-
ment of PVD in the fetus with CLHO as an important diag-
nostic adjunct in planning perinatal management of these
high-risk cases.
CLHO lesions compromise 15% to 20% of all congenital
heart defects that are diagnosed prenatally.19 Between 6%
and 20% of these infants will require EAS after birth because
of an intact (6%) or a highly restrictive (20%) atrial
septum.1-4 The overall prevalence of RAS in our study cohort
is 15% (6/39), which is consistent with prior reports.1-4
Prenatal identification of RAS has previously been important
because it allows for additional parental counseling regarding
the increased morbidity and mortality observed in these
infants. Accurate identification of RAS also permits more
precise patient selection for either a nonstandard delivery
strategy or selection for fetal cardiac intervention.6,9
However, despite prenatal identification of RAS and the
implementation of a perinatal strategy to allow for prompt992 The Journal of Thoracic and Cardiovascular Surgcardiology evaluation and treatment, infants with CLHO
lesions complicated by RAS still have poor short- and
long-term outcomes.1,2,20,21 This is supported by our
current series in which 30-day survival was only 50%,
despite the use of novel strategies such as EXIT-to-ECMO
and cesarean delivery in the hybrid catheterization suite.
Poor short-term survival despite prenatal diagnosis of RAS
has prompted select centers to perform in utero atrial septo-
plasty to relieve left atrial hypertension, thus, theoretically
preventing the irreversible changes to the pulmonary
vasculature.
The feasibility of a novel delivery strategy or in utero in-
tervention depends not only on the ability to execute these
interventions but also on the ability to accurately predictery c April 2011
FIGURE 5. Proposed algorithm to assist clinicians in diagnosing RAS and determining the probability of postnatal EAS. RAS, Restrictive atrial septum;
VTI, time-velocity integral; EAS, emergency atrial septostomy.
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rent study demonstrates that PVD flow patterns, in the set-
ting of a small or absent interatrial communication, are able
to reliably identify fetuses with CLHO who will require
EAS, both in late second and third trimesters. Although
our previous analysis of PVD patterns had suggested that
using an FRVTI ratio less than 5 was the strongest predictor
of RAS in the newborn period, our subsequent experience
suggests that lowering the PVD FR VTI ratio threshold to
3 or less would have increased specificity and PPV. Al-
though changing the threshold value in this way may affect
sensitivity, this may, nonetheless, be a preferable strategy
when considering maternal interventions that add risk of
morbidity to the mother.
Within the current study cohort, we again noted the var-
iability of fetal pulmonary venous spectral Doppler patterns
that correlate with RAS on postnatal evaluation (Figure 4).
Specifically, not every neonate with CLHO and confirmed
RAS will have the biphasic fetal PVD profile—consisting
of a large S wave, absent D wave, and large A-wave
reversal—described as the ‘‘type C’’ pattern by Taketazu
and colleagues.13 This pattern would generally produceThe Journal of Thoracic and Caa PVD FR VTI ratio of approximately 1 and correlated in
their study to fetuses with intact atrial septum. Our findings
demonstrate that EAS is not uncommonly required in pa-
tients with small interatrial communications and PVD FR
VTI ratios of 3 or less, which broadens the scope of ‘‘at
risk’’ fetuses identified using our proposed threshold values.
Review of the longitudinal data demonstrated that 30 of
32 (94%) late second-trimester PVD FR VTI ratios did
not change significantly with respect to the threshold levels
when compared with those obtained during the later third
trimester. In 5 of 6 fetuses with an FR VTI ratio 3 or less
at initial study, the ratio remained 3 or less on follow-up
study and correlated postnatally with confirmed RAS.
These findings have implications for patient selection for
fetal atrial septoplasty, because these procedures are usually
undertaken in the late second trimester in an effort to affect
the development of pulmonary vascular changes.9,22 These
findings have led us to consider an algorithmic approach
to evaluation of the fetus with CHLO at risk of RAS
(Figure 5). On the basis of our most recent experience,
our approach has evolved toward recommending C/S in
the cardiac catheterization laboratory for FR VTI less thanrdiovascular Surgery c Volume 141, Number 4 993
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that does not preclude attempts at a vaginal birth in subse-
quent pregnancies. EXIT-to-ECMO, on the other hand,
requires deep maternal anesthesia to control uterine tone
and often requires a vertical incision, which increases the
risk to the mother during the current and possibly future
deliveries.
Limitations to this study include the small sample size
and retrospective study design, which may limit our ability
to generalize our findings. We also acknowledge that man-
agement of high-risk infants such as these is likely institu-
tion or provider dependent, which may make it more or
less likely that an infant with the same clinical presentation
would undergo EAS.
CONCLUSIONS
Because the mother incurs added risks when in utero or
alternate delivery strategies are implemented, we believe
that using a PVD FRVTI ratio of 3 or less allows for iden-
tification of infants with a high likelihood of requiring EAS
in the newborn period while eliminating false-positive
results. In those fetuses with ratios between 3 and 5 in
whom it is more difficult to predict postnatal outcome, we
would recommend serial evaluations and a more cautious
prenatal counseling approach with regard to the strategy
for delivery and our ability to accurately predict the need
for EAS in the newborn period. Overall, the results of the
longitudinal data set suggest that the PVD FR VTI ratios
obtained in late second trimester are consistent with values
observed at later gestation and, as such, could be reliably
used for patient selection for in utero interventions, partic-
ularly in fetuses with an FR VTI ratio of 3 or less.
The authors thank YuWang, MS, for expertise and input regard-
ing the statistical analysis used in this article.
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